• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiopulm Rehabil Prev . Adverse Impact of COVID-19 on Hopelessness Levels in Patients With Ischemic Heart Disease

tetano

Editor, Senior Moderator
J Cardiopulm Rehabil Prev


. 2025 Aug 5.
doi: 10.1097/HCR.0000000000000960. Online ahead of print. Adverse Impact of COVID-19 on Hopelessness Levels in Patients With Ischemic Heart Disease

Susan L Dunn[SUP] 1 [/SUP], Holli A DeVon, Eileen G Collins, Anna Luong, Heather Pauls Hrynyk, Mia I Cajita, Nathan L Tintle



Affiliations
Abstract

Purpose: The coronavirus disease-2019 (COVID-19) pandemic negatively impacted mental health outcomes. This study aimed to 1) quantify the relationship between perceived impact of COVID-19 and hopelessness in patients with ischemic heart disease (IHD) and 2) identify potential mediators of the relationship.
Methods: Participants (n = 110) were recruited from 1 hospital in the Midwestern United States. Data on the perceived impact of COVID-19, state and trait hopelessness, depression, perceived social support (PSS), health-related quality of life (HRQoL), and well-being were collected 2 weeks post-hospitalization from 2020 to 2023. Linear models were used to evaluate associations between variables in adjusted and unadjusted models.
Results: Most participants were male (69%), non-Hispanic White (95%), married (64%), and with some college education (66%). Hopelessness showed a modest association with perceived COVID-19 impact (state = 0.23; trait = 0.30), as did anxiety (0.40), HRQoL (0.20), PSS (-0.24), fatigue (0.25), and pain interference (0.25), in adjusted and unadjusted models. Food access, family income/employment, social support access, and stress were associated with hopelessness and perceived COVID-19 impact. The strongest evidence for mediation between hopelessness and perceived COVID-19 impact was anxiety (66% mediation state; 50% mediation trait).
Conclusions: In this first study to report hopelessness levels in patients with IHD during the COVID-19 pandemic, the relationship between hopelessness and perceived COVID-19 impact was supported and mediated by anxiety. During a pandemic, food access, social support, family income/employment, and stress in patients with IHD may increase feelings of hopelessness. Further research is required to examine the hopelessness and anxiety relationship.

Keywords: COVID-19; anxiety; hopelessness; ischemic heart disease.

 
Back
Top